BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9547126)

  • 1. Effects of comorbidity and polypharmacy on the clinical usefulness of sertraline in elderly depressed patients: an open multicentre study.
    Arranz FJ; Ros S
    J Affect Disord; 1997 Dec; 46(3):285-91. PubMed ID: 9547126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open study of sertraline in acute and continuation treatment of depressed out-patients.
    Van Houdenhove B; Onghena P; Floris M; Janssen F; De Nayer AR; Boxus A; Iancu H
    J Int Med Res; 1997; 25(6):340-53. PubMed ID: 9427167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
    Kavoussi RJ; Segraves RT; Hughes AR; Ascher JA; Johnston JA
    J Clin Psychiatry; 1997 Dec; 58(12):532-7. PubMed ID: 9448656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertraline effectiveness and safety in depressed oncological patients.
    Torta R; Siri I; Caldera P
    Support Care Cancer; 2008 Jan; 16(1):83-91. PubMed ID: 17874143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
    Rabkin JG; Wagner G; Rabkin R
    J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling acute episodes of depression.
    Lapierre YD
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():23-35. PubMed ID: 1806627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.
    Aguglia E; Casacchia M; Cassano GB; Faravelli C; Ferrari G; Giordano P; Pancheri P; Ravizza L; Trabucchi M; Bolino F
    Int Clin Psychopharmacol; 1993; 8(3):197-202. PubMed ID: 8263318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open, baseline controlled evaluation of sertraline safety and efficacy in the treatment of depression in Thai patients.
    SESS Group (Sertraline Efficacy and Safety Study Group)
    J Med Assoc Thai; 2001 Jan; 84(1):54-62. PubMed ID: 11281500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of depression in real-life settings: knowledge gained from large-scale clinical trials.
    Thompson C
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():21-5. PubMed ID: 7963447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice.
    Ekselius L; von Knorring L; Eberhard G
    Int Clin Psychopharmacol; 1997 Nov; 12(6):323-31. PubMed ID: 9547134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline.
    Krishnan KR; Doraiswamy PM; Clary CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):347-61. PubMed ID: 11294481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priapism with sertraline and lithium.
    Mendelson WB; Franko T
    J Clin Psychopharmacol; 1994 Dec; 14(6):434-5. PubMed ID: 7884031
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
    Cohn CK; Shrivastava R; Mendels J; Cohn JB; Fabre LF; Claghorn JL; Dessain EC; Itil TM; Lautin A
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():28-33. PubMed ID: 2258379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice.
    Doogan DP; Langdon CJ
    Int Clin Psychopharmacol; 1994; 9(2):95-100. PubMed ID: 8057000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toleration and safety of sertraline: experience worldwide.
    Doogan DP
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():47-56. PubMed ID: 1806630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open study of sertraline in patients with major depression who failed to respond to moclobemide.
    George T; Theodoros MT; Chiu E; Krapivensky N; Hokin A; Tiller JW
    Aust N Z J Psychiatry; 1999 Dec; 33(6):889-95. PubMed ID: 10619217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of the pharmacology of sertraline.
    Warrington SJ
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():11-21. PubMed ID: 1806626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline and speech blockage.
    Makela EH; Sullivan P; Taylor M
    J Clin Psychopharmacol; 1994 Dec; 14(6):432-3. PubMed ID: 7884029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.